NCT07129486View on ClinicalTrials.gov

Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Obstructive Sleep Apnea (OSA)
Interventions
DEVICE

CPAP

Continuous positive airway pressure (CPAP) is the standard treatment for moderate to severe OSA in clinical practice.

Trial Locations (1)

112

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

Kun-Ta Chou

OTHER_GOV

NCT07129486 - Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins | Biotech Hunter | Biotech Hunter